Open dataset · Monthly and after detected source changes
GLP-1 Required-Fee Burden Index
The index measures how much of a calculable low-end recurring total comes from a required non-medication fee.
Key findings from FormBlends Research
The data
| Provider | Offer | Medication low | Fee low | Fee high | Fee share | Source |
|---|---|---|---|---|---|---|
| Ro | Wegovy pen | 349 | 74 | 149 | 17.5 | Ro |
| Ro | Zepbound | 399 | 74 | 149 | 15.6 | Ro |
| Mochi | Compounded semaglutide | 60 | 66.33 | 79 | 52.5 | Mochi Health |
| Mochi | Compounded tirzepatide | 90 | 66.33 | 79 | 42.4 | Mochi Health |
| Hims | Wegovy pill | 149 | 149 | 149 | 50 | Hims |
| Hims | Zepbound | 299 | 149 | 149 | 33.3 | Hims |
| LifeMD | Weight management + medication | 149 | 75 | 75 | 33.5 | LifeMD |
| Eden | Compounded semaglutide | 99 | 99 | 99 | 50 | Eden |
| Eden | Compounded tirzepatide | 199 | 99 | 99 | 33.2 | Eden |
| Sesame | Weight-loss program + brand medication | 149 | 59 | 99 | 28.4 | Sesame |
Methodology
- 1. Include offers with both a recurring medication price and a required fee above zero.
- 2. Use the low end of each disclosed range for the comparable fee-share calculation.
- 3. Keep unknown fees out of the denominator rather than treating them as zero.
Limits
- • These are derived measurements from public offer pages, not patient quotes, clinical ratings, or endorsements.
- • Null means the cited page did not establish the field; it does not mean zero.
- • Checkout-only terms, eligibility, state, pharmacy, dose, taxes, and promotions can change the patient-specific amount.
Source ledger
company · accessed 2026-08-25
Ro
Weight Loss Program Pricing
company · accessed 2026-08-25
Mochi Health
New Per-Dose Pricing: What Changed
company · accessed 2026-08-26
Hims
Weight Loss Treatments
company · accessed 2026-08-26
LifeMD
LifeMD Memberships
company · accessed 2026-08-26
Eden
GLP-1 Treatments
company · accessed 2026-08-26
Sesame
Online Weight Loss Program